Harvest Fund Management Co. Ltd purchased a new stake in shares of American Healthcare REIT, Inc. (NYSE:AHR – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 7,796 shares of the company’s stock, valued at approximately $203,000.
Several other hedge funds have also bought and sold shares of AHR. Kozak & Associates Inc. purchased a new position in shares of American Healthcare REIT in the 3rd quarter valued at about $28,000. Kiely Wealth Advisory Group Inc. acquired a new stake in American Healthcare REIT in the second quarter valued at approximately $30,000. Amalgamated Bank purchased a new stake in shares of American Healthcare REIT in the second quarter valued at approximately $33,000. Tidemark LLC acquired a new position in shares of American Healthcare REIT during the 3rd quarter worth approximately $44,000. Finally, Semmax Financial Advisors Inc. purchased a new position in shares of American Healthcare REIT during the 2nd quarter valued at approximately $45,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.
American Healthcare REIT Price Performance
American Healthcare REIT stock opened at $29.57 on Thursday. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59. The company has a 50-day moving average price of $26.11 and a 200 day moving average price of $20.20. American Healthcare REIT, Inc. has a 12-month low of $12.63 and a 12-month high of $29.81. The stock has a market cap of $4.53 billion and a P/E ratio of -61.60.
American Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, October 18th. Stockholders of record on Friday, September 20th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.38%. The ex-dividend date of this dividend was Friday, September 20th. American Healthcare REIT’s dividend payout ratio is presently -208.33%.
Wall Street Analyst Weigh In
A number of research firms have weighed in on AHR. JMP Securities upped their price objective on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, September 20th. Morgan Stanley upped their price target on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, August 22nd. KeyCorp lifted their price objective on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday, September 16th. Royal Bank of Canada increased their target price on American Healthcare REIT from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Monday, November 18th. Finally, Bank of America lifted their price target on American Healthcare REIT from $27.00 to $31.00 and gave the stock a “buy” rating in a research note on Tuesday, September 24th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and an average target price of $25.13.
View Our Latest Stock Analysis on AHR
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Further Reading
- Five stocks we like better than American Healthcare REIT
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 5 discounted opportunities for dividend growth investors
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.